Saturday, 08 August 2020


Zenotec Biotech to invest in R&D of new technology

30 January 2013 | News | By BioSpectrum Bureau

The investment will be made to set up a pilot plant and further R&D

The investment will be made to set up a pilot plant and further R&D

Singapore: Zenotec Biotechnology, a bioscience start-up founded in October 2012, will invest $993,267 (RM3.06 million) to develop its collagen wound healing management product. The product is specially designed for glaucoma and diabetes patients.

News reports emerging from Malaysia stated that the tissue re-engineering and wound healing technology of Zenotec Biotechnology is believed to be the first-of-its-kind in the region.

Zenotec Biotechnology is one of the incubatees at Technology Park Malaysia's Biotech Incubation Center in Kuala Lumpur. The technology of the company was acquired from a renowned Taiwanese inventor and will be enhancement further through R&D for the intellectual property to be patented in Malaysia.

The investment will be made to set up a pilot plant and further R&D on the acquired technology.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls